Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live5/18/2026, 1:56:48 AM
sha256:0015cContent snapshot
{ "design_id": "SCIDEX-SS31-ALT-01", "sequence": "RYKW", "target_protein": "cardiolipin-rich mitochondrial inner membrane", "score": 1, "method": "codex-rosalind-agentic-design", "related_paper_id": "pmid:23813215", "metadata": { "intent": "research_only_hypothesis_generating_artifact", "sources": [ { "id": "23813215", "doi": "10.1681/ASN.2012121216", "note": "SS-31 interacts with cardiolipin and protects cristae in an ischemia model.", "type": "pmid" }, { "id": "32273339", "doi": "10.1074/jbc.RA119.012094", "note": "SS-31 binds lipid bilayers and modulates surface electrostatics.", "type": "pmid" }, { "id": "35913044", "doi": "10.7554/eLife.75531", "note": "Tetrapeptide SAR for alternating aromatic/cationic mitochondrial compounds.", "type": "pmid" }, { "cid": "11764719", "name": "elamipretide", "note": "Metadata anchor for the reference SS-31 compound.", "type": "pubchem" } ], "source_refs": [ "pmid:23813215", "doi:10.1681/ASN.2012121216", "pmid:32273339", "doi:10.1074/jbc.RA119.012094", "pmid:35913044", "doi:10.7554/eLife.75531", "pubchem:CID11764719" ], "uncertainty": "This candidate is an unvalidated surrogate inspired by SS-31 literature and may or may not preserve cardiolipin-facing membrane behavior.", "codex_run_id": "codex-run:a754f0917f8d8299", "design_class": "SS-31-like short aromatic-cationic peptidomimetic", "file_records": [ { "path": "lab_notes.md", "bytes": 4209, "sha256": "6149e0b216493f31d1d54f106133bc98d6658bb4d9dd84fd89e172a1a10c308d" }, { "path": "design_description.md", "bytes": 2152, "sha256": "53a6af8976c0279af2311040719bf9365892587e9d1bde4fe020bfdc34f4db4c" }, { "path": "descriptor_score.py", "bytes": 4403, "sha256": "26320ab7c8b5e6d6d4231f709e75e1723f9075f9f7a6b1d446f09e40b155e2de" }, { "path": "manifest.json", "bytes": 1534, "sha256": "b9ca395f0aadf9170380f1a2e9d91ee88a981cfb8a6d4934ce780ebf796ecc20" } ], "safety_scope": "research_only_not_medical_advice_no_dosing_no_efficacy_claim", "workspace_path": "/home/ubuntu/SciDEX-Agents/.codex-worktrees/kris-rosalind-persona/state/rosalind-kris/codex-runs/codex-run:a754f0917f8d8299/workspace", "work_packet_ref": "agent_work_packet:e9f8cbe5-2ee7-4510-9d75-f9708b1f2a2b", "descriptor_score": { "flags": [], "length": 4, "sequence": "RYKW", "flag_score": 100, "total_score": 100, "length_score": 100, "balance_score": 100, "aromatic_count": 2, "cationic_count": 2, "alternation_score": 100, "canonical_sequence": "RYKW" }, "artifact_locations": { "schema": "scidex-artifact-locations@v1", "locations": [ { "name": "github", "state": "legacy_source", "provider": "github", "commit_sha": "882bc7d1e5c1e9fe9d7d66fb37d66f6eb4e435ec", "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159", "repository_url": "https://github.com/SciDEX-AI/scidex-artifacts.git", "sparse_checkout_patterns": [ "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" ] }, { "name": "forgejo", "repo": "scidex-artifacts", "owner": "scidex-mirrors", "state": "active", "web_url": "https://forge.scidex.ai/scidex-mirrors/scidex-artifacts", "provider": "forgejo", "repo_mode": "collection", "commit_sha": "6cd239a50e3a9a8f03baa17f492e7a2a16a43c2c", "repo_class": "protein-design", "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159", "repository_url": "https://forge.scidex.ai/scidex-mirrors/scidex-artifacts.git", "sparse_checkout_patterns": [ "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" ] } ], "migration": { "to": "forgejo_living_artifact_repo", "from": "github_sparse_repo", "tool": "scidex_artifact_location_migration.py", "migrated_at": "2026-05-20T02:30:28+00:00" }, "repo_mode": "collection", "primary_ref": "protein_design:173f0f28-4c51-412f-8330-1ebfdf868159", "artifact_refs": [ "protein_design:173f0f28-4c51-412f-8330-1ebfdf868159", "notebook:7d229db7-2033-4d1a-80e1-63419c4d866a", "analysis:ff7d6dda-a627-47fe-a221-bf56317a1fec", "analysis:4aaf1fb4-9bd9-4709-87c5-d095072b5fea", "agent_work_packet:e9f8cbe5-2ee7-4510-9d75-f9708b1f2a2b", "evidence_link:0c5a4196-036b-4fa9-b520-fe1fe188199a", "evidence_link:41fd5516-ca9e-4f39-ae20-aa71f6c4cac9", "evidence_link:9f738120-78f4-496d-8b75-2b2d6dab61f6", "evidence_link:058e61c8-987d-42a2-bcd0-21e93f977163" ], "blob_locations": [ { "uri": "s3://scidex-artifacts/protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/", "name": "s3", "state": "active_blob_store", "provider": "s3", "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" } ], "active_git_location": "forgejo" }, "sparse_artifact_repo": { "commit": "a9de0160ce6befeff68063a023224ea8f2a397dc", "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159", "repository_url": "/home/ubuntu/scidex-artifacts", "sparse_checkout_patterns": [ "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" ] }, "codex_run_analysis_ref": "analysis:4aaf1fb4-9bd9-4709-87c5-d095072b5fea", "artifact_location_active": { "commit": "6cd239a50e3a9a8f03baa17f492e7a2a16a43c2c", "provider": "forgejo", "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159", "location_name": "forgejo", "repository_url": "https://forge.scidex.ai/scidex-mirrors/scidex-artifacts.git", "sparse_checkout_patterns": [ "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" ] }, "sparse_checkout_verified": { "path": "/tmp/scidex-sparse-checkout-173f0f28-4c51-412f-8330-1ebfdf868159", "files": [ "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/README.md", "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/descriptor_score.py", "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/design_description.md", "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/lab_notes.md", "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/manifest.json", "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159/scidex_refs.json" ], "bundle_path": "protein_design/173f0f28-4c51-412f-8330-1ebfdf868159" }, "modified_sequence_notation": "H-Arg-Tyr-Lys-Trp-NH2" }, "target_function": "binder", "target_id": "cardiolipin", "target_family": "mitochondrial-lipid-binding-peptide", "fold": "short-aromatic-cationic-tetrapeptide", "domain": "mitochondrial membrane biophysics", "summary": "# Design Description\n\n## Artifact name\n`SCIDEX-SS31-ALT-01`\n\n## One-line description\nA research-only SS-31-like tetrapeptide surrogate, `H-Arg-Tyr-Lys-Trp-NH2` (`RYKW`), proposed as a hypothesis-generating cardiolipin-facing membrane binder for mitochondrial inner-membrane studies.\n\n## Rationale\nThis candidate preserves the core SS-31 design logic described in the source literature:\n\n- short tetrapeptide length\n- alternating cationic and aromatic side chains\n- compact sequence suitable for membrane interaction studies\n- emphasis on cardiolipin-rich inner mitochondrial membrane behavior\n\nThe specific change from the SS-31 reference motif is the use of tryptophan in place of phenylalanine to increase aromatic bulk and provide a different aromatic interaction surface. This is only a design hypothesis. It does not imply improved function, safety, or translational value.\n\n## Sequence representation\n- Canonical surrogate sequence: `RYKW`\n- Modified peptide notation: `H-Arg-Tyr-Lys-Trp-NH2`\n\n## What this is not\n- Not a medical recommendation\n- Not a therapeutic claim\n- Not a validated mitochondrial drug candidate\n- Not an optimized structure\n\n## Expected qualitative properties\n- Two cationic residues should support electrostatic interaction with anionic lipid environments.\n- Two aromatic residues should support membrane association and a compact SS-31-like pattern.\n- The alternating register should keep the sequence in the same design family as the reference compounds.\n\n## Uncertainty statement\nThe mechanistic link between sequence choice and cardiolipin stabilization remains uncertain. The reference literature supports the broader motif class, but not this exact surrogate sequence.\n\n## Suggested next experiments\n- Compare `RYKW` against SS-31 and a scrambled control in cardiolipin-containing membrane assays.\n- Measure binding or partitioning under matched salt and lipid-composition conditions.\n- Assess whether the candidate changes membrane electrostatics in a direction consistent with the SS-31 literature.\n- Check whether the peptide adopts a compact membrane-associated conformation or remains more extended than SS-31.\n" }